Natural Product: NPC1272

Natural Product IDNPC1272
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
(3S,8S,9S,10R,13S,14S,16S,17R)-17-[(2S,3S,6R)-3,7-Dihydroxy-6-Methylheptan-2-Yl]-10,13-Dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1H-Cyclopenta[A]Phenanthrene-3,16-Diol
IUPAC Name (3S,8S,9S,10R,13S,14S,16S,17R)-17-[(2S,3S,6R)-3,7-dihydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,16-diol
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL2088136
PubChem CID 70695378
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0001445] Bile acids, alcohols and derivatives
          • [CHEMONTID:0002194] Hydroxy bile acids, alcohols and derivatives
            • [CHEMONTID:0001110] Tetrahydroxy bile acids, alcohols and derivatives

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey HJMSZKKOQIZOLJ-XPMUQOCRSA-N
Standard InCHI InChI=1S/C27H46O4/c1-16(15-28)5-8-23(30)17(2)25-24(31)14-22-20-7-6-18-13-19(29)9-11-26(18,3)21(20)10-12-27(22,25)4/h6,16-17,19-25,28-31H,5,7-15H2,1-4H3/t16-,17-,19+,20-,21+,22+,23+,24+,25+,26+,27+/m1/s1
SMILES C[C@H](CC[C@@H]([C@@H](C)[C@H]1[C@H](C[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O)O)O)CO

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   434.34 Volume:   473.847
?
Van der Waals volume.
Dense:   0.917 LogP:   3.89
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.801
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.259
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   6.0 Rigid Bonds:   20.0
TPSA:   80.92
?
Topological Polar Surface Area.
H-Bond Acceptor:   4.0
H-Bond Donor:   4.0 Rings:   4.0
Heavy Atoms:   4.0

MedChem Properties

QED Drug-Likeness Score:   0.47 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.852 Fsp3:   0.926
MCE-18:   72.154
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.694 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.014
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.0
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.391 Promiscuous compounds:   0.048

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.425 MDCK Permeability:   -5.162
Pgp-inhibitor:   0.045 Pgp-substrate:   0.987
PAMPA:   0.984
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.012 30% Bioavailability (F30%):   0.057
50% Bioavailability (F50%):   0.972

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.003 MRP1:   0.506
Plasma Protein Binding (PPB):   69.165% Volume Distribution (VD):   -0.202
Fu: 29.704%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   0.971 BCRP inhibitor:   0.32
BSEP inhibitor:   0.039

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.001
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.016
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.029
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.57
HLM stability:   0.014
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  13.018 Half-life (T1/2):  1.798

ADMET: Toxicity

hERG Blockers:  0.05 hERG Blockers (10um):  0.199
Human Hepatotoxicity (H-HT):  0.668 Drug-induced Liver Injury (DILI):  0.117
AMES Toxicity:  0.153 Rat Oral Acute Toxicity:  0.085
Maximum Recommended Daily Dose:  0.35 Skin Sensitization:  0.983
Carcinogencity:  0.566 Eye Corrosion:  0.004
Eye Irritation:  0.714 Respiratory Toxicity:  0.491
Drug-induced Neurotoxicity:  0.02 Ototoxicity:  0.898
Hematotoxicity:  0.273 Drug-induced Nephrotoxicity:  0.679
Genotoxicity:  0.004 RPMI-8226 Immunitoxicity:  0.079
A549 Cytotoxicity:  0.577 Hek293 Cytotoxicity:  0.351
BCF:   0.619
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.124
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.533
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.73
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33234 chamaellirium luteum Species n.a. n.a. roots sourced from Botanical Liaisons Ltd. (USA) and Blessed Herbs Ltd. (USA) n.a. PMID[22880631]
NPO33234 chamaellirium luteum Species n.a. n.a. n.a. n.a. n.a. Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1523 Cell line NFF Homo sapiens IC50 > 50.0 ug.mL-1 PMID[16441091]
NPT165 Cell line HeLa Homo sapiens IC50 > 50.0 ug.mL-1 PMID[11549443]
NPT139 Cell line HT-29 Homo sapiens IC50 > 50.0 ug.mL-1 PMID[1602299]
NPT83 Cell line MCF7 Homo sapiens IC50 > 50.0 ug.mL-1 DOI[10.6019/CHEMBL1201861]
NPT1524 Cell line MM96L Homo sapiens IC50 > 50.0 ug.mL-1 PMID[12617583]
NPT111 Cell line K562 Homo sapiens IC50 > 50.0 ug.mL-1 PMID[23398362]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC1272 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC470614
0.8 Intermediate Similarity NPC124172
0.678 Remote Similarity NPC477522
0.6607 Remote Similarity NPC600590
0.6491 Remote Similarity NPC328313
0.6441 Remote Similarity NPC321381
0.625 Remote Similarity NPC176012
0.6034 Remote Similarity NPC107059
0.5862 Remote Similarity NPC162742
0.5862 Remote Similarity NPC304309
0.5862 Remote Similarity NPC470228
0.5763 Remote Similarity NPC22105
0.5763 Remote Similarity NPC221758
0.5763 Remote Similarity NPC34019
0.5738 Remote Similarity NPC51014
0.5714 Remote Similarity NPC96319
0.5667 Remote Similarity NPC136188
0.5667 Remote Similarity NPC28657
0.5667 Remote Similarity NPC474216
0.5667 Remote Similarity NPC154330
0.5574 Remote Similarity NPC230301
0.5574 Remote Similarity NPC113733
0.5574 Remote Similarity NPC198968
0.5574 Remote Similarity NPC285893
0.5574 Remote Similarity NPC134847
0.5484 Remote Similarity NPC241290
0.5484 Remote Similarity NPC164840
0.5484 Remote Similarity NPC484739
0.5484 Remote Similarity NPC209944
0.5484 Remote Similarity NPC264245
0.5484 Remote Similarity NPC155986
0.541 Remote Similarity NPC20688
0.5397 Remote Similarity NPC328714
0.5323 Remote Similarity NPC76879
0.5312 Remote Similarity NPC472265
0.5312 Remote Similarity NPC318495
0.5312 Remote Similarity NPC33913
0.5312 Remote Similarity NPC59453
0.5303 Remote Similarity NPC47761
0.5246 Remote Similarity NPC151519
0.5231 Remote Similarity NPC26117
0.5231 Remote Similarity NPC19607
0.5231 Remote Similarity NPC603646
0.5152 Remote Similarity NPC243985
0.5152 Remote Similarity NPC473943
0.5152 Remote Similarity NPC280710
0.5152 Remote Similarity NPC240650
0.5152 Remote Similarity NPC155011
0.5075 Remote Similarity NPC474164
0.5075 Remote Similarity NPC488870
0.5072 Remote Similarity NPC601043
0.5072 Remote Similarity NPC605412

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC1272 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5763 Remote Similarity NPD4786 Phase 1
0.5714 Remote Similarity NPD3701 Pre-clinical
0.5667 Remote Similarity NPD6942 Phase 4
0.5574 Remote Similarity NPD7339 Approved
0.5246 Remote Similarity NPD3667 Phase 4

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data